Evidence map›Paper›PMID 39565744›Full record

ArticlePloS one2024

Prrx1-driven LINC complex disruption in vivo reduces osteoid deposition but not bone quality after voluntary wheel running.

Scott Birks, Sean Howard, Christian S Wright, Caroline O'Rourke, Elicza A Day, Alexander J Lamb, James R Walsdorf, Anthony Lau, William R Thompson, Gunes Uzer

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Scott BirksMicron School of Materials Science and Engineering, Boise State University, Boise, Idaho, United States of America.
Sean HowardMechanical and Biomedical Engineering, Boise State University, Boise, Idaho, United States of America.
Christian S WrightDepartment of Physical Therapy, Indiana University, Bloomington, Indiana, United States of America.
Caroline O'RourkeBiomedical Engineering, The College of New Jersey, Ewing Township, New Jersey, United States of America.
Elicza A DayDepartment of Physical Therapy, Indiana University, Bloomington, Indiana, United States of America.
Alexander J LambDepartment of Physical Therapy, Indiana University, Bloomington, Indiana, United States of America.
James R WalsdorfDepartment of Physical Therapy, Indiana University, Bloomington, Indiana, United States of America.
Anthony LauBiomedical Engineering, The College of New Jersey, Ewing Township, New Jersey, United States of America.
William R ThompsonDepartment of Physical Therapy, Indiana University, Bloomington, Indiana, United States of America.
Gunes UzerMechanical and Biomedical Engineering, Boise State University, Boise, Idaho, United States of America.ORCID 0000-0002-1178-4942

Funding

VPS35 D620N inhibits autophagy through disrupted hyaluronic acid-CD44 signalingP20GM109095 · NIGMS · BOISE STATE UNIVERSITY · PI OCHOA-REPARAZ, JAVIER · 2014 to 2023
$22.7M
Optimizing Deep Brain Stimulation for Parkinson's Disease.P20GM148321 · NIGMS · BOISE STATE UNIVERSITY · PI Javier Ochoa-Reparaz · 2023 to 2026
$10.2M
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering ComplexR01AR074473 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI THOMPSON, WILLIAM ROY · 2018 to 2023
$2.8M
Role of force regulated nuclear structure in expression of osteogenesisR01AR075803 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBIN, JANET E · 2020 to 2024
$2.4M
Role of LINC-mediated Mechanosignaling in MSC AgingR01AG059923 · NIA · BOISE STATE UNIVERSITY · PI UZER, GUNES · 2020 to 2024
$1.6M
Live Cell Imaging System for Biomechanics and Mechanobiology ResearchS10OD032354 · OD · BOISE STATE UNIVERSITY · PI UZER, GUNES · 2022 to 2022
$233k
NIAMS NIH HHS R01 AR074473NIAMS NIH HHS R01 AR075803NIA NIH HHS R01 AG059923NIGMS NIH HHS P20 GM109095NIGMS NIH HHS P20 GM148321NIH HHS S10 OD032354
6 · The paper itself

Abstract

The Linker of Nucleoskeleton and Cytoskeleton (LINC) complex serves to connect the nuclear envelope and the cytoskeleton, influencing cellular processes such as nuclear arrangement, architecture, and mechanotransduction. The role LINC plays in mechanotransduction pathways in bone progenitor cells has been well studied; however, the mechanisms by which LINC complexes govern in vivo bone formation remain less clear. To bridge this knowledge gap, we established a murine model disrupting LINC using transgenic Prx-Cre mice and floxed Tg(CAG-LacZ/EGFP-KASH2) mice. Prx-Cre mice express the Cre recombinase enzyme controlled by the paired-related homeobox gene-1 promoter (Prrx1), a pivotal regulator of skeletal development. Prx-Cre animals have been widely used in the bone field to target bone progenitor cells. Tg(CAG-LacZ/EGFP-KASH2) mice carry a lox-stop-lox flanked LacZ gene allowing for the overexpression of an EGFP-KASH2 fusion protein via cre recombinase mediated deletion of the LacZ cassette. This disrupts endogenous Nesprin-Sun binding in a dominant negative manner disconnecting nesprin from the nuclear envelope. By combining these lines, we generated a Prrx1(+) cell-specific LINC disruption model to study its impact on the developing skeleton and subsequently exercise-induced bone accrual. The findings presented here indicate Prx-driven LINC disruption (PDLD) cells exhibit no change in osteogenic and adipogenic potential compared to controls in vitro nor are there bone quality changes when compared to in sedentary animals at 8 weeks. While PDLD animals displayed increased voluntary running activity andPrrx1(+) cell-specific LINC disruption abolished the exercise-induced increases in osteoid volume and surface after a 6-week exercise intervention, no other changes in bone microarchitecture or mechanical properties were found.

Indexed as

Homeodomain ProteinsMice, TransgenicAnimalsBone and BonesIntegrasesMaleMiceNerve Tissue ProteinsOsteogenesisPhysical Conditioning, AnimalRunningHomeodomain ProteinsIntegrasesNerve Tissue ProteinsPrrx1 protein, mouse

Identifiers

PMID39565744
PMCPMC11578491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.